Raymond Wenhou Zhou
NIH Rank #9617
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 14307455Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2025
Linked Award Amount
$1.5M
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#9,617
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Raymond Wenhou Zhou as a PI. Multi-PI records show the full award amount for context.
- 5R42CA285234-03R42Extended half-life GlyTR1 combined with checkpoint blockade for Cancer Immunotherapy$1.1Maward amount
- 1R42CA302415-01A1R42Maximizing GlyTR pan-cancer immunotherapy by enhancing target density$463.5Kaward amount
Award organization
Organizations that administered FY2025 awards listing Raymond Wenhou Zhou as a PI.
FY2025 award administered by Glytr Therapeutics, Inc. (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024ScienceDex Coverage BeginsEarliest loaded PI award records: FY2024
- 2024$500K Cumulative Linked Award Amount
- 2025$1M Cumulative Linked Award Amount
- 2025$2M Cumulative Linked Award Amount
- 2025Reached Top 50% by Award-Linked RankRanked #9617
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Raymond Wenhou Zhou.